193 related articles for article (PubMed ID: 26220665)
41. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis.
Dessein PH; López-Mejias R; González-Juanatey C; Genre F; Miranda-Filloy JA; Llorca J; González-Gay MA
J Rheumatol; 2014 Mar; 41(3):429-36. PubMed ID: 24488413
[TBL] [Abstract][Full Text] [Related]
42. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity.
Foltz V; Gandjbakhch F; Etchepare F; Rosenberg C; Tanguy ML; Rozenberg S; Bourgeois P; Fautrel B
Arthritis Rheum; 2012 Jan; 64(1):67-76. PubMed ID: 21904998
[TBL] [Abstract][Full Text] [Related]
43. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
Le Loët X; Brazier M; Mejjad O; Boumier P; Daragon A; Gayet A; Pouplin S; Tron F; Zarnitsky C; Vittecoq O; Menard JF; Fardellone P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1739-47. PubMed ID: 20740612
[TBL] [Abstract][Full Text] [Related]
44. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels.
Kim H; Ku SY; Suh CS; Kim SH; Kim JH; Kim JG
Arch Gynecol Obstet; 2012 Jul; 286(1):147-53. PubMed ID: 22392486
[TBL] [Abstract][Full Text] [Related]
45. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
46. Osteoprotegerin in patients with degenerative aortic stenosis and preserved left-ventricular ejection fraction.
Borowiec A; Dąbrowski R; Kowalik I; Firek B; Chwyczko T; Janas J; Szwed H
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):444-50. PubMed ID: 25930677
[TBL] [Abstract][Full Text] [Related]
47. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort.
Seror R; Boudaoud S; Pavy S; Nocturne G; Schaeverbeke T; Saraux A; Chanson P; Gottenberg JE; Devauchelle-Pensec V; Tobón GJ; Mariette X; Miceli-Richard C
Sci Rep; 2016 Jan; 6():18421. PubMed ID: 26785768
[TBL] [Abstract][Full Text] [Related]
48. The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney.
Candido R
Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):69-74. PubMed ID: 24247823
[TBL] [Abstract][Full Text] [Related]
49. OPG/TRAIL ratio as a predictive biomarker of mortality in patients with type A acute aortic dissection.
Lu J; Li P; Ma K; Li Y; Yuan H; Zhu J; Duan W; Ou J; Huang Y; Wu L; Pan X; Zhang H; Du J; Li Y
Nat Commun; 2021 Jun; 12(1):3401. PubMed ID: 34099729
[TBL] [Abstract][Full Text] [Related]
50. Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
Wang P; Li S; Liu LN; Lv TT; Li XM; Li XP; Pan HF
Clin Rheumatol; 2017 Oct; 36(10):2193-2200. PubMed ID: 28698901
[TBL] [Abstract][Full Text] [Related]
51. Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).
Vishvanath A; Itinteang T; Tan ST; Day DJ
Histopathology; 2011 Sep; 59(3):397-406. PubMed ID: 22034880
[TBL] [Abstract][Full Text] [Related]
52. The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker?
Castellino G; Corallini F; Bortoluzzi A; La Corte R; Lo Monaco A; Secchiero P; Zauli G; Trotta F
Rheumatology (Oxford); 2010 Jun; 49(6):1173-6. PubMed ID: 20299382
[TBL] [Abstract][Full Text] [Related]
53. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.
van Tuyl LH; Voskuyl AE; Boers M; Geusens P; Landewé RB; Dijkmans BA; Lems WF
Ann Rheum Dis; 2010 Sep; 69(9):1623-8. PubMed ID: 20525836
[TBL] [Abstract][Full Text] [Related]
54. Concentration of osteoprotegerin (OPG) in peritoneal fluid is increased in women with endometriosis.
Harada M; Osuga Y; Hirata T; Hirota Y; Koga K; Yoshino O; Morimoto C; Fujiwara T; Momoeda M; Yano T; Tsutsumi O; Taketani Y
Hum Reprod; 2004 Oct; 19(10):2188-91. PubMed ID: 15242994
[TBL] [Abstract][Full Text] [Related]
55. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis.
Ammitzbøll CG; Thiel S; Jensenius JC; Ellingsen T; Hørslev-Petersen K; Hetland ML; Junker P; Krogh NS; Østergaard M; Stengaard-Pedersen K
Arthritis Rheum; 2013 Dec; 65(12):3045-50. PubMed ID: 24022747
[TBL] [Abstract][Full Text] [Related]
56. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
Shipman CM; Croucher PI
Cancer Res; 2003 Mar; 63(5):912-6. PubMed ID: 12615702
[TBL] [Abstract][Full Text] [Related]
57. Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in tumour cell survival?
Holen I; Cross SS; Neville-Webbe HL; Cross NA; Balasubramanian SP; Croucher PI; Evans CA; Lippitt JM; Coleman RE; Eaton CL
Breast Cancer Res Treat; 2005 Aug; 92(3):207-15. PubMed ID: 16155791
[TBL] [Abstract][Full Text] [Related]
58. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
[TBL] [Abstract][Full Text] [Related]
59. Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis.
Kim J; Song TJ; Yang SH; Lee OH; Nam HS; Kim YD; Kim EH; Lee HS; Nam CM; Heo JH
Clin Biochem; 2013 Aug; 46(12):1036-1040. PubMed ID: 23726804
[TBL] [Abstract][Full Text] [Related]
60. Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort.
Meyer M; Sellam J; Fellahi S; Kotti S; Bastard JP; Meyer O; Lioté F; Simon T; Capeau J; Berenbaum F
Arthritis Res Ther; 2013; 15(6):R210. PubMed ID: 24314299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
